Ascendis Pharma A/S Proceeds From Borrowings Classified As Financing Activities
Ascendis Pharma A/S (ASND) reported Proceeds From Borrowings Classified As Financing Activities of EUR 0 for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities · last filed 2026-02-11
- Ascendis Pharma A/S proceeds from borrowings classified as financing activities for the quarter ending 2025-12-31 was 0.00 EUR.
- Ascendis Pharma A/S proceeds from borrowings classified as financing activities for the quarter ending 2024-12-31 was 0.00 EUR.
- Ascendis Pharma A/S proceeds from borrowings classified as financing activities for the quarter ending 2023-12-31 was -3.53M EUR.
- Ascendis Pharma A/S proceeds from borrowings classified as financing activities for the quarter ending 2022-12-31 was 0.00 EUR.
| Period end | Proceeds From Borrowings Classified As Financing Activities 3 month | Proceeds From Borrowings Classified As Financing Activities 9 month | Proceeds From Borrowings Classified As Financing Activities 12 month |
|---|---|---|---|
| 2025-12-31 | 0.00 EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 0.00 EUR 20-F · filed 2026-02-11 | |
| 2025-09-30 | 0.00 EUR 6-K · filed 2025-11-12 | ||
| 2024-12-31 | 0.00 EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 134.16M EUR 20-F · filed 2026-02-11 | |
| 2024-09-30 | 134.16M EUR 6-K · filed 2025-11-12 | ||
| 2023-12-31 | -3.53M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 136.26M EUR 20-F · filed 2026-02-11 | |
| 2023-09-30 | 139.78M EUR 6-K · filed 2024-11-14 | ||
| 2022-12-31 | 0.00 EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | 503.28M EUR 20-F · filed 2025-02-12 | |
| 2022-09-30 | 503.28M EUR 6-K · filed 2023-11-07 | ||
| 2021-12-31 | 0.00 EUR 20-F · filed 2024-02-07 |